By www.reliableresearchiq.com
Global Galectin-3 Inhibitor Market Research Report 2024 Story
94
$ 2900
Galectin-3 Inhibitor Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
GlycoMimetics (US) Galectin Therapeutics Inc (US) G3 Pharmaceuticals (India) iTeos (US) MandalMed, Inc (US) Angion (US) Novartis AG (Switzerland) Galecto Biotech (Denmark) Pfizer Inc. (US) Lilly (US)